In vitro anti-hepatitis B virus effect of Hypericum perforatum L.

Abstract

The anti-hepatitis B virus (HBV) effects and its mechanisms of the ethanol extracts of Hypericum perforatum L. (EHP) in vitro were explored. HepG2 2.2.15 cells, a stable HBV-producing cell line, were cultured as the model system to observe the anti-HBV effect. The viral antigens of cellular secretion, HBsAg and HBeAg, were determined by enzyme linked immunosorbent assay (ELISA). The quantity of HBV-DNA released in the supernatant was assayed by real-time PCR. In order to understand the mechanisms of the suppression of HBV replication, all HBV promoters (Cp, Xp, S1p, S2p and Fp) with luciferase reporter gene were transfected into HepG2 cells respectively. Then the activities of viral promoters were examined by luciferase reporter assay. It was found EHP effectively suppressed the secretion of HBsAg and HBeAg from HepG2 2.2.15 cells in a dose-dependent manner, as well as the extracellular HBV DNA. And EHP could selectively inhibit the activity of HBV promoter Fp. Our data suggest that EHP exerts anti-HBV effects via inhibition of HBV transcription, which helps to elucidate the mechanism underlying the potential therapeutic value of EHP.

Keywords

hepatitis B virus / Hypericum perforatum L. / HBsAg / HBeAg / HBV DNA / HBV promoter

References

[1] SavikinK., DobricS., TadicV., et al.. Antiinflammatory activity of ethanol extracts of Hypericum perforatum L., H. barbatum Jacq., H. hirsutum L., H. richeri Vill. and H. androsaemum L. in rats. Phytother Res, 2007, 21(2): 176-180

[2] RoscettiG., FranzeseO., ComandiniA., et al.. Cytotoxic activity of Hypericum perforatum L. on K562 erythroleukemic cells: differential effects between methanolic extract and hypericin. Phytother Res, 2004, 18(1): 66-72

[3] JacobsonJ.M., FeinmanL., LiebesL., et al.. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John’s wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother, 2001, 45(2): 517-524

[4] ValentaoP., CarvalhoM., FernandesE., et al.. Protective activity of Hypericum androsaemum infusion against tert-butyl hydroperoxide-induced oxidative damage in isolated rat hepatocytes. J Ethnopharmacol, 2004, 92(1): 79-84

[5] UsaiM., LeggioB., GrappiS., et al.. Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum. Pharmacopsychiatry, 2003, 36(6): 283-287

[6] YeP., ZhangS.L., ZhaoL., et al.. Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line. J Huazhong Univ Sci Technol Med Sci, 2009, 29(2): 169-172

[7] MoollaN., KewM., ArbuthnotP.. Regulatory elements of hepatitis B virus transcription. J Viral Hepat, 2002, 9(5): 323-331

[8] ChoiB.H., ParkG.T., RhoH.M.. Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J Biol Chem, 1999, 274(5): 2858-2865

[9] ParkN.H., SongI.H., ChungY.H.. Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J, 2006, 82(970): 507-515

[10] LiawY.F.. Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat, 2002, 9(6): 393-399

[11] SellsM.A., ChenM.L., AcsG.. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A, 1987, 84(4): 1005-1009

[12] XuJ., WangJ., DengF., et al.. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res, 2008, 78(3): 242-249

[13] LiJ., HuangH., FengM., et al.. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L. Antiviral Res, 2008, 79(2): 114-120

[14] ChenC.J., YangH.I., SuJ., et al.. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA, 2006, 295(1): 65-73

[15] IloejeU.H., YangH.I., SuJ., et al.. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology, 2006, 130(3): 678-686

[16] YangH.I., LuS.N., LiawY.F., et al.. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med, 2002, 347(3): 168-174

[17] HoshidaY.. Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence. J Hepatol, 2009, 51(5): 842-844

[18] WuC.F., YuM.W., LinC.L., et al.. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis, 2008, 29(1): 106-112

[19] McMahonB.J.. The natural history of chronic hepatitis B virus infection. Hepatology, 2009, 49(5Suppl): S45-S55

[20] ChenG., LinW., ShenF., et al.. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol, 2006, 101(8): 1797-1803

[21] TongQ., WuY., LuoD.. Distribution of hepatitis B virus genotypes and its clinical significance in Hubei province, China. J Huazhong Univ Sci Technol Med Sci, 2007, 27(3): 274-277

[22] HowardC.R.. The structure of hepatitis B envelope and molecular variants of hepatitis B virus. J Viral Hepat, 1995, 2(4): 165-170

[23] ArbuthnotP., CarmonaS., ElyA.. Exploiting the RNA interference pathway to counter hepatitis B virus replication. Liver Int, 2005, 25(1): 9-15

[24] ShamayM., BarakO., DoitshG., et al.. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem, 2002, 277(12): 9982-9988

[25] TangH., BanksK.E., AndersonA.L., et al.. Hepatitis B virus transcription and replication. Drug News Perspect, 2001, 14(6): 325-334

[26] ChouY.C., YuM.W., WuC.F., et al.. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut, 2008, 57(1): 91-97

[27] KwonJ.A., RhoH.M.. Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappaB binding site. Biochem Cell Biol, 2002, 80(4): 445-455